KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares RepurchasedShort-Term Debt issuances
Ratios

Abbott Laboratories (ABT) Short-Term Debt issuances (2016 - 2025)

Historic Short-Term Debt issuances for Abbott Laboratories (ABT) over the last 17 years, with Q3 2025 value amounting to $8.0 million.

  • Abbott Laboratories' Short-Term Debt issuances fell 8181.82% to $8.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$18.0 million, marking a year-over-year decrease of 2000.0%. This contributed to the annual value of -$100.0 million for FY2024, which is 57619.05% down from last year.
  • Latest data reveals that Abbott Laboratories reported Short-Term Debt issuances of $8.0 million as of Q3 2025, which was down 8181.82% from -$16.0 million recorded in Q2 2025.
  • Over the past 5 years, Abbott Laboratories' Short-Term Debt issuances peaked at $111.0 million during Q4 2023, and registered a low of -$197.0 million during Q4 2021.
  • Over the past 5 years, Abbott Laboratories' median Short-Term Debt issuances value was $5.0 million (recorded in 2022), while the average stood at -$14.7 million.
  • As far as peak fluctuations go, Abbott Laboratories' Short-Term Debt issuances tumbled by 1960000.0% in 2021, and later soared by 101000.0% in 2023.
  • Abbott Laboratories' Short-Term Debt issuances (Quarter) stood at -$197.0 million in 2021, then skyrocketed by 105.08% to $10.0 million in 2022, then skyrocketed by 1010.0% to $111.0 million in 2023, then plummeted by 76.58% to $26.0 million in 2024, then tumbled by 69.23% to $8.0 million in 2025.
  • Its Short-Term Debt issuances was $8.0 million in Q3 2025, compared to -$16.0 million in Q2 2025 and -$36.0 million in Q1 2025.